- Home
- NERV vs INFU Comparison
NERV vs INFU Comparison
Compare NERV & INFU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NERV | INFU |
|---|---|---|
| Founded | 2007 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medical/Dental Instruments |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 228.5M | 196.1M |
| IPO Year | 2014 | 2005 |
Fundamental Metrics
Financial Performance| Metric | NERV | INFU |
|---|---|---|
| Price | $5.23 | $9.43 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $7.00 | ★ $15.00 |
| AVG Volume (30 Days) | ★ 332.2K | 89.2K |
| Earning Date | 05-12-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 181.82 |
| EPS | N/A | ★ 0.31 |
| Revenue | $41,175,600.00 | ★ $143,436,000.00 |
| Revenue This Year | N/A | $3.20 |
| Revenue Next Year | N/A | $7.31 |
| P/E Ratio | ★ N/A | $29.97 |
| Revenue Growth | N/A | ★ 6.36 |
| 52 Week Low | $1.15 | $4.66 |
| 52 Week High | $12.46 | $11.04 |
Technical Indicators
Market Signals| Indicator | NERV | INFU |
|---|---|---|
| Relative Strength Index (RSI) | 34.08 | 53.91 |
| Support Level | $5.02 | $8.52 |
| Resistance Level | $6.69 | $9.89 |
| Average True Range (ATR) | 0.60 | 0.40 |
| MACD | -0.26 | -0.07 |
| Stochastic Oscillator | 6.54 | 56.51 |
Price Performance
Historical ComparisonAbout NERV Minerva Neurosciences Inc
Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.
About INFU InfuSystems Holdings Inc.
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.